River BioMedics is a Dutch start-up biotech company that specializes in cardiac drug discovery. Established in 2020 as a spin-off from the University of Twente, the company is driven by the vision of generating a flow of innovation in the field of cardiovascular health. Inspired by the flowing river that supplies different cities, just like the heart supplies organs in our body, River BioMedics develops cutting-edge 3D cardiac models.

With a team comprising experts in Stem Cell Technologies, Biochemistry, Drug Innovation, Pharmacy, Engineering, and Medicine, the company is uniquely positioned to tackle the challenges associated with cardiac drug development. By leveraging their combined expertise, River BioMedics aims to revolutionize the field and take cardiac drug development to new heights. Recent achievements include securing a €2 million seed investment, receiving a €1.

45 million grant from EIC-Transition, and being awarded a €4 million grant from EIC-Pathfinder Challenge. With a commitment to innovation and scientific excellence, River BioMedics is paving the way for advancements in cardiovascular medicine. Contact them today to learn more about their groundbreaking work